Carnitine in maternal and neonatal plasma.

Area of Science:

• Biochemistry
• Perinatal Medicine
• Nutritional Science

Background:

• Carnitine is essential for fatty acid metabolism.
• Pregnancy and the neonatal period involve significant metabolic changes.
• Understanding carnitine transport and levels is crucial for maternal and infant health.

Purpose of the Study:

• To investigate total plasma carnitine levels in pregnant women undergoing caesarean section and their neonates.
• To determine the relationship between maternal and neonatal carnitine levels.
• To assess the impact of maternal glucose or saline infusion on carnitine levels.

Main Methods:

• Analysis of total plasma carnitine in 19 pregnant women and their neonates.
• Random allocation to receive either glucose or saline infusion prior to elective caesarean section.
• Measurement of non-esterified fatty acids and 3-OH-butyrate in infant plasma.

Main Results:

• Maternal plasma carnitine levels were significantly lower than in non-pregnant women and lower than in their neonates at delivery.
• No significant difference in maternal or infant carnitine levels was observed between the glucose and saline groups.
• A positive correlation was found between maternal and infant plasma carnitine levels.
• Infant plasma levels of non-esterified fatty acids and 3-OH-butyrate differed between groups at delivery but normalized by 4 hours.

Conclusions:

• Maternal plasma carnitine concentration is the primary determinant of neonatal plasma carnitine levels.
• Intrapartum maternal glucose or saline infusion does not appear to affect maternal or neonatal carnitine levels.
• Carnitine status during pregnancy warrants further investigation due to its lower levels and importance for fetal development.